Free Access
Issue
Med Sci (Paris)
Volume 40, Number 12, Décembre 2024
Épigénétique : développement et destin cellulaire
Page(s) 976 - 978
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2024167
Published online 20 December 2024
  1. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science 2018 ; 359 : 1350–5. [CrossRef] [PubMed] [Google Scholar]
  2. Vétizou M, Daillère R, Zitvogel L. Microbiote intestinal et réponses aux thérapies anti-tumorales. Med Sci (Paris) 2016 ; 32 : 974–82. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Pronost M, Duflot I, Motte A. Le microbiote intestinal : un acteur de la réponse aux immunothérapies dans le cancer pulmonaire ? Med Sci (Paris) 2022 ; 38 : 963–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Guillot N, Roméo B, Manesh SS, et al. Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality. Trends Mol Med 2023 ; 29 : 897–911. [CrossRef] [PubMed] [Google Scholar]
  5. Davar D, Dzutsev AK, McCulloch JA, et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients. Science 2021 ; 371 : 595–602. [CrossRef] [PubMed] [Google Scholar]
  6. Tissandié E, Guéguen Y, A.Lobaccaro J-M, et al. Vitamine D : Métabolisme, régulation et maladies associées. Med Sci (Paris) 2006 ; 22 : 1095–100. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Aggeletopoulou I, Tsounis EP, Mouzaki A, Triantos C. Exploring the role of vitamin D and the vitamin D receptor in the composition of the gut microbiota. Front Biosci-Landmark 2023 ; 28. [Google Scholar]
  8. Bikle D, Christakos S. New aspects of vitamin D metabolism and action: addressing the skin as source and target. Nat Rev Endocrinol 2020 ; 16 : 234–52. [CrossRef] [PubMed] [Google Scholar]
  9. Giampazolias E, Pereira da Costa M, Lam KC, et al. Vitamin D regulates microbiome-dependent cancer immunity. Science 2024 ; 384 : 428–37. [CrossRef] [PubMed] [Google Scholar]
  10. Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015 ; 350 : 1079–84. [CrossRef] [PubMed] [Google Scholar]
  11. Muñoz A, Grant WB. Vitamin D and cancer: An historical overview of the epidemiology and mechanisms. Nutrients 2022 ; 14 : 1448. [CrossRef] [PubMed] [Google Scholar]
  12. Zhang R, Zhang Y, Liu Z, et al. Association between vitamin D supplementation and cancer mortality: A systematic review and meta-analysis. Cancers 2022 ; 14 : 3717. [CrossRef] [PubMed] [Google Scholar]
  13. Vanherwegen A-S, Gysemans C, Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism. Mol Cell Endocrinol 2017 ; 453 : 52–67. [CrossRef] [PubMed] [Google Scholar]
  14. Triantos C, Aggeletopoulou I, Mantzaris GJ, Mouzaki A. Molecular basis of vitamin D action in inflammatory bowel disease. Autoimmun Rev 2022 ; 21 : 103136. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.